US Broker Ratings

GSK plc (GSK) Stock Analysis: 15% Potential Upside Amid Strong Dividend Yield

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, stands as a compelling case for investors seeking stability and growth in the drug manufacturing industry...

Thermo Fisher Scientific Inc. (TMO): Investor Outlook with a 1.49% Potential Upside and Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO), a stalwart in the Healthcare sector, has made waves with its robust presence in the Diagnostics & Research industry. With..

BioNTech SE (BNTX) Stock Analysis: Evaluating a 17.86% Potential Upside Amidst Revenue Challenges

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured investor attention with its innovative strides in immunotherapy and mRNA vaccine development. Headquartered..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Powerhouse with 14.68% Potential Upside

Cencora, Inc. (NYSE: COR), a stalwart in the healthcare sector, has captured the attention of investors with its expansive reach in the medical distribution industry. As..

HCA Healthcare, Inc. (HCA) Stock Analysis: Strong Revenue Growth and Analyst Optimism Signal Promising Upside

HCA Healthcare, Inc. (NYSE: HCA), a titan in the U.S. medical care facilities industry, currently boasts a market capitalization of $90.46 billion. This Nashville, Tennessee-headquartered company..

Abbott Laboratories (ABT) Stock Analysis: A Healthy Outlook with a 6.87% Upside

Abbott Laboratories (NYSE: ABT) stands as a formidable player in the healthcare sector, specializing in medical devices. With a market capitalization of $194.62 billion, this American..

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Target Price Suggests a 21.41% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK) stands as a formidable presence in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With its..

CVS Health Corporation (CVS) Stock Analysis: A 24.74% Potential Upside with Strong Analyst Support

Investors eyeing opportunities in the healthcare sector should take a closer look at CVS Health Corporation (NYSE: CVS), a titan in the healthcare plans industry. With..

Gilead Sciences, Inc. (GILD) Stock Analysis: Exploring Growth Potential Amidst a Robust 8.05% Upside

Gilead Sciences, Inc. (NASDAQ: GILD) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a market capitalization of $180.64..

McKesson Corporation (MCK) Stock Analysis: Evaluating a 10.47% Potential Upside for Healthcare Investors

McKesson Corporation (NYSE: MCK), a titan in the healthcare sector, continues to captivate investor interest with its robust market presence and promising financial outlook. With a..

Eli Lilly (LLY) Stock Analysis: Navigating Strong Revenue Growth and a $1.05 Trillion Market Cap

Eli Lilly and Company (NYSE: LLY) stands as a formidable player in the healthcare sector, boasting a market capitalization of $1.05 trillion. Specializing in the discovery,..

Pfizer, Inc. (PFE) Stock Analysis: Is the 6.15% Dividend Yield a Golden Opportunity for Investors?

Pfizer, Inc. (NYSE: PFE), standing as a titan in the healthcare sector, has long been a staple in the portfolios of many investors. Known for its..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Is a 3.96% Upside Worth the Investment?

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a heavyweight in the biotechnology sector, continues to captivate investor attention with its robust market position and innovative therapeutic offerings. With..

AstraZeneca PLC (AZN) Stock Analysis: Unraveling a 30.63% Potential Upside Within the Healthcare Sector

AstraZeneca PLC (AZN), a prominent global player in the biopharmaceutical industry, presents a compelling opportunity for investors with its robust pipeline of prescription medicines and strategic..

Danaher Corporation (DHR) Stock Report: Analyst Ratings Signal Strong Buy Potential

Danaher Corporation (NYSE: DHR), a heavyweight in the diagnostics and research industry, is making waves in the healthcare sector. With a robust market capitalization of $151.89..

UnitedHealth Group (UNH) Stock Analysis: A Healthcare Titan with 20.94% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a stalwart in the healthcare plans industry, commands a formidable presence with a market capitalization of $352.71 billion. As a leader..

PPHE Hotel Group appoints Yoav Papouchado as Non-Executive Director

PPHE Hotel Group has appointed Yoav Papouchado as a non-executive director and said it will review the Board’s overall composition and balance...

Nuvalent, Inc. (NUVL) Stock Analysis: Evaluating Growth Potential Amidst a Steady Market Position

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the healthcare sector with its innovative approach to cancer treatment...

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Is the 17.55% Potential Upside Worth the Risk?

Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a prominent player in the biotechnology sector, is renowned for its focus on developing RNA-targeted therapeutics and genetic therapies aimed at..

Inspire Medical Systems (INSP) Stock Analysis: Navigating the Sleep Apnea Market with High Valuation and Mixed Ratings

Inspire Medical Systems, Inc. (NYSE: INSP), a prominent player in the healthcare sector, is gaining attention for its innovative approach to treating obstructive sleep apnea (OSA)..

Search

Funds

US Broker Ratings

PPHE Hotel Group appoints Yoav Papouchado as Non-Executive Director

PPHE Hotel Group has appointed Yoav Papouchado as a non-executive director and said it will review the Board’s overall composition and balance...
Search

Funds

US Broker Ratings

FTSE 100

Funds